Cargando…
Erratum to “Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients”
Autores principales: | Lee, Sang Jin, Park, Won, Park, Sung Hwan, Shim, Seung-Cheol, Baek, Han Joo, Yoo, Dae-Hyun, Kim, Hyun Ah, Lee, Soo Kon, Lee, Yun Jong, Park, Young Eun, Cha, Hoon-Suk, Park, Jin Kyun, Lee, Eun Young, Lee, Eun Bong, Song, Yeong Wook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585674/ https://www.ncbi.nlm.nih.gov/pubmed/28913368 http://dx.doi.org/10.1155/2017/7869412 |
Ejemplares similares
-
Low Baseline Interleukin-17A Levels Are Associated with Better Treatment Response at 12 Weeks to Tocilizumab Therapy in Rheumatoid Arthritis Patients
por: Lee, Sang Jin, et al.
Publicado: (2015) -
Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
por: Baek, Han Joo, et al.
Publicado: (2019) -
Limited efficacy of tocilizumab in adult patients with secondary hemophagocytic lymphohistiocytosis: a retrospective cohort study
por: Kim, Ju Yeon, et al.
Publicado: (2022) -
Impact of Dose Tapering of Tumor Necrosis Factor Inhibitor on Radiographic Progression in Ankylosing Spondylitis
por: Park, Jun Won, et al.
Publicado: (2016) -
Baseline peripheral blood neutrophil-to-lymphocyte ratio could predict survival in patients with adult polymyositis and dermatomyositis: A retrospective observational study
por: Ha, You-Jung, et al.
Publicado: (2018)